Drug recall D-915-2013
Product
IRINOTECAN HYDROCHLORIDE INJECTION, 40 mg/2 mL (20 mg/mL), 2 mL Single Dose Vial, Rx only, Manufactured for: APP Pharmaceuticals, LLC, Schaumburg, IL 60173, NDC 63323-193-02, UPC 3 63323 19302 7.
Reason for recall
Crystallization: Active pharmaceutical ingredient is precipitating in product solution.
Lots and codes
Lot #: 872CZ00101, Exp 12/13
Recall details
- Recalling firm
- Fresenius Kabi USA LLC (FK USA), Schaumburg, IL
- Quantity
- 23,672 vials
- Distribution
- Nationwide
- Type
- Voluntary: Firm initiated
- Recall initiated
- January 22, 2013
- Terminated
- May 12, 2015
Related products
- NDC 63323-193 Irinotecan Hydrochloride · Irinotecan Hydrochloride 20 mg/mL · Fresenius Kabi USA, LLC